Cutler Group LP Ac Immune Sa Call Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 Apr 14, 2022	SELL	$3.5 - $5.16 $2,800 - $4,128	-800 Closed	0 $0
Q4 2021 Jan 18, 2022	SELL	$4.83 - $7.56 $28,497 - $44,604	-5,900 Reduced 88.06%	800 $0
Q3 2021 Oct 26, 2021	BUY	$6.2 - $8.34 $41,540 - $55,878	6,700 New	6,700 $1,000
Q2 2021 Jul 19, 2021	SELL	$6.04 - $8.37 $604 - $836	-100 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$5.32 - $8.96 $532 - $896	100 New	100 $0

27.9M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $224M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.